PBI26 THE ECONOMIC REASON FOR THE USE OF VEDOLIZUMAB COMPARED WITH INHIBITORS OF TNF-ALPHA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON THE EXAMPLE OF MOSCOW
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.130
https://www.valueinhealthjournal.com/article/S1098-3015(19)32508-2/fulltext
Title :
PBI26 THE ECONOMIC REASON FOR THE USE OF VEDOLIZUMAB COMPARED WITH INHIBITORS OF TNF-ALPHA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON THE EXAMPLE OF MOSCOW
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32508-2&doi=10.1016/j.jval.2019.09.130
First page :
Section Title :
Open access? :
No
Section Order :
10088